3D Endoanal Ultrasound and Anal Fistula (UFU)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03937752|
Recruitment Status : Completed
First Posted : May 6, 2019
Last Update Posted : March 30, 2020
|Condition or disease||Intervention/treatment|
|Anal Fistula||Other: 3D endodanal ultrasound|
|Study Type :||Observational|
|Actual Enrollment :||95 participants|
|Official Title:||The Role of 3D Endoanal Ultrasound in Management of Anal Fistulas|
|Actual Study Start Date :||April 1, 2018|
|Actual Primary Completion Date :||March 26, 2020|
|Actual Study Completion Date :||March 26, 2020|
Patients with anal fistulas, no previous fistula procedures. Ultrasound investigation done as a part of surgical treatment, such as loose seton or fistulotomy.
Other: 3D endodanal ultrasound
Endoanal ultrasound performed with two different transducers preoperatively during a fistula treatment procedure.
Other Name: 3D endoanal ultrasonography
- Fistula position [ Time Frame: Day 1 ]Dorsal? Ventral? Lateral - right or left?
- Fistula level [ Time Frame: Day 1 ]Level I-IV (how much of the sphincter is affected?)
- Fistula length [ Time Frame: Day 1 ]Shorter or longer than 3 cm?
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03937752
|Pelvic Floor Centre|
|Principal Investigator:||Ursula Aho Fält, MD||Region Skane|